Zydus Lifesciences Limited — Others, 13-11-2024: Copy of Newspaper Publication

Zydus Lifesciences Limited has announced a board meeting to discuss the financial results for the quarter and half-year ended September 30, 2024. The consolidated unaudited results reveal total income from operations at ₹52,370 million, with a net profit after tax and non-controlling interest of ₹9,112 million. The earnings per share for continuing operations stand at ₹9.05. This performance indicates growth compared to the previous year's quarter, suggesting a strengthening financial position. Investors might perceive this update as a positive outlook, reflecting the company's ability to deliver increased profitability amid market challenges.